(VIANEWS) - Axcelis Technologies (ACLS), Vertex Pharmaceuticals (VRTX), Avista Corporation (AVA) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Axcelis Technologies (ACLS)
43.6% sales growth and 12.96% return on equity
Axcelis Technologies, Inc. designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia.
Axcelis Technologies's sales growth this year is anticipated to be 31.8% and 10.4% for next year.
Year-on-year quarterly revenue growth grew by 19.8%, now sitting on 512.65M for the twelve trailing months.
Volume
Today's last reported volume for Axcelis Technologies is 791299 which is 187.08% above its average volume of 275635.
Axcelis Technologies's sales growth for the next quarter is 43.6%. The company's growth estimates for the present quarter and the next is 131.2% and 134.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.96%.
Volatility
Axcelis Technologies's last day, last week, and last month's current volatility was 1.95%, 2.20%, and 2.14%, respectively.
Axcelis Technologies's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 10.97% (day), 5.30% (last week), and 4.23% (last month), respectively.
Axcelis Technologies's Stock Yearly Top and Bottom Value
Axcelis Technologies's stock is valued at $57.91 at 01:22 EST, under its 52-week high of $59.58 and way above its 52-week low of $23.60.
Axcelis Technologies's Moving Average
Axcelis Technologies's worth is way higher than its 50-day moving average of $49.83 and way higher than its 200-day moving average of $43.66.2. Vertex Pharmaceuticals (VRTX)
17.4% sales growth and 23.83% return on equity
Vertex Pharmaceuticals Incorporated engages in developing and commercializing therapies for treating cystic fibrosis.
Vertex Pharmaceuticals's sales growth this year is anticipated to be 17.5% and 10.5% for next year.
Year-on-year quarterly revenue growth grew by 17.6%, now sitting on 6.68B for the twelve trailing months.
Volume
Today's last reported volume for Vertex Pharmaceuticals is 2231270 which is 33.71% above its average volume of 1668700.
Vertex Pharmaceuticals's sales growth is a negative 0% for the present quarter and 17.4% for the next. The company's growth estimates for the ongoing quarter and the next is 15.9% and 24.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 23.83%.
Volatility
Vertex Pharmaceuticals's last day, last week, and last month's current volatility was 2.72%, 2.20%, and 1.19%, respectively.
Vertex Pharmaceuticals's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.24% (day), 2.86% (last week), and 2.00% (last month), respectively.
Vertex Pharmaceuticals's Stock Yearly Top and Bottom Value
Vertex Pharmaceuticals's stock is valued at $192.85 at 01:22 EST, way below its 52-week high of $242.99 and above its 52-week low of $176.36.
Vertex Pharmaceuticals's Moving Average
Vertex Pharmaceuticals's worth is above its 50-day moving average of $183.26 and below its 200-day moving average of $197.69.Previous days news about Vertex Pharmaceuticals(VRTX)
- Vertex pharmaceuticals inc. Q3 adjusted earnings beat estimates. According to Business Insider on Tuesday, 2 November, "Excluding items, Vertex Pharmaceuticals Inc. reported adjusted earnings of $926 million or $3.56 per share for the period."
3. Avista Corporation (AVA)
12.8% sales growth and 7.2% return on equity
Avista Corporation operates as an electric and natural gas utility company.
Avista Corporation's sales growth this year is anticipated to be 8.3% and 4.9% for next year.
Year-on-year quarterly revenue growth grew by 7.1%, now sitting on 1.36B for the twelve trailing months.
Volume
Today's last reported volume for Avista Corporation is 342651 which is 25.44% below its average volume of 459580.
Avista Corporation's sales growth for the next quarter is 12.8%. The company's growth estimates for the ongoing quarter and the next is a negative 0% and negative -9.4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 7.2%.
Volatility
Avista Corporation's last day, last week, and last month's current volatility was 1.30%, 1.41%, and 1.38%, respectively.
Avista Corporation's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.07% (day), 2.46% (last week), and 2.57% (last month), respectively.
Avista Corporation's Stock Yearly Top and Bottom Value
Avista Corporation's stock is valued at $40.55 at 01:22 EST, way below its 52-week high of $49.14 and way above its 52-week low of $33.49.
Avista Corporation's Moving Average
Avista Corporation's value is above its 50-day moving average of $39.84 and under its 200-day moving average of $42.92.4. Legacy Housing Corporation (LEGH)
9.8% sales growth and 15.55% return on equity
Legacy Housing Corporation builds, sells, and finances manufactured homes and tiny houses primarily in the southern United States.
Legacy Housing Corporation's sales growth this year is expected to be 7.5% and 10.3% for next year.
Year-on-year quarterly revenue growth grew by 5.6%, now sitting on 180.97M for the twelve trailing months.
Volume
Today's last reported volume for Legacy Housing Corporation is 15319 which is 58.97% below its average volume of 37338.
Legacy Housing Corporation's sales growth is a negative 0% for the present quarter and 9.8% for the next. The company's growth estimates for the ongoing quarter and the next is 22.9% and 4.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 15.55%.
Volatility
Legacy Housing Corporation's last day, last week, and last month's current volatility was 2.14%, 0.98%, and 1.21%, respectively.
Legacy Housing Corporation's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.81% (day), 2.50% (last week), and 2.61% (last month), respectively.
Legacy Housing Corporation's Stock Yearly Top and Bottom Value
Legacy Housing Corporation's stock is valued at $18.09 at 01:22 EST, way below its 52-week high of $20.29 and way higher than its 52-week low of $13.11.